Observational studyJournal of the American Heart Association2026
Clinical Impact of Switching From or Persisting With Rivaroxaban or Apixaban After a Bleeding Event: A Real-World Study in Patients With Nonvalvular Atrial Fibrillation.
Gregory Y H Lip et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.